Filtered By:
Education: Study
Countries: Spain Health
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 551 results found since Jan 2013.
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
CONCLUSIONS: Among AF patients anticoagulated with rivaroxaban, HF patients had a worse clinical profile and a higher MACE risk and cardiovascular mortality. HF was independently associated with the development of MACE, but not with thromboembolic events or major bleeding.PMID:36200548 | DOI:10.5603/CJ.a2022.0091
Source: Cardiology Journal - October 6, 2022 Category: Cardiology Authors: Manuel Anguita S ánchez Francisco Mar ín Jaime Masjuan Juan Cos ín-Sales Jos é Manuel Vázquez Rodríguez Vivencio Barrios Gonzalo Bar ón-Esquivias I ñaki Lekuona Alejandro I P érez-Cabeza Rom án Freixa-Pamias Francisco Javier Parra Jimenez Mohame Source Type: research
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain
CONCLUSIONS: In Spain, CKD population is older and comorbidities, including diabetes and heart failure, are common. Cardiovascular and renal outcomes are frequent. There is room for improvement in CKD management, particularly through the use of drugs with proven cardiovascular and renal benefit.PMID:36165157 | DOI:10.1016/j.nefroe.2022.01.008
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - September 27, 2022 Category: Urology & Nephrology Authors: Carlos Escobar Unai Aranda Beatriz Palacios Margarita Capel Antoni Sicras Aram Sicras Antonio Hormigo Roberto Alc ázar Nicol ás Manito Manuel Botana Source Type: research
